Globe Life Earnings Call Transcripts
Fiscal Year 2026
-
Q1 saw double-digit net operating income growth, strong premium increases in both life and health, and robust investment income. Guidance was raised for EPS and share repurchases, with AI and technology investments expected to drive further margin expansion and productivity gains.
Fiscal Year 2025
-
Fourth quarter net income and operating income rose year-over-year, with strong premium growth in both life and health segments. 2026 guidance calls for continued earnings and premium growth, supported by technology investments and favorable market trends, while capital returns remain robust.
-
Q3 net income and operating income rose sharply year-over-year, with strong premium growth and improved underwriting margins across segments. 2025 guidance calls for continued premium and EPS growth, robust share repurchases, and stable capital metrics, supported by technology investments and favorable mortality trends.
-
Q2 net operating income rose 10% year-over-year, with strong life and health premium growth and improved margins. Guidance for 2025 was raised, driven by favorable mortality, technology-driven sales gains, and robust capital returns. Bermuda reinsurance affiliate expected to enhance future cash flow.
-
Q1 2025 saw net income of $255M and 10% growth in net operating income, with life and health premiums up but health margins pressured by higher claims. Guidance for 2025 is reaffirmed, with EPS expected to grow 11% and strong capital return plans in place.
Fiscal Year 2024
-
Q4 2024 saw strong premium growth and improved operating income, with robust agent count and sales momentum across most segments. Guidance for 2025 points to continued premium and earnings growth, ongoing share repurchases, and a focus on capital efficiency, despite elevated health claim utilization and open regulatory inquiries.
-
Q3 2024 saw strong earnings growth, with net income and operating income up significantly year-over-year. Life and health premiums rose, agent counts increased, and share repurchases accelerated. 2025 guidance projects continued growth in earnings, premiums, and cash flow.
-
Q2 2024 saw strong earnings growth, robust premium and investment income increases, and a 14% rise in book value per share. An independent review found no evidence of financial misconduct, and the company raised its full-year EPS guidance while accelerating share repurchases.